Health Catalyst, Inc.
HCAT
$1.34
-$0.14-9.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 302.48M | 311.14M | 316.06M | 316.09M | 311.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 302.48M | 311.14M | 316.06M | 316.09M | 311.27M |
| Cost of Revenue | 149.90M | 156.50M | 165.96M | 170.68M | 168.28M |
| Gross Profit | 152.58M | 154.63M | 150.11M | 145.41M | 143.00M |
| SG&A Expenses | 89.14M | 94.15M | 97.16M | 96.54M | 94.90M |
| Depreciation & Amortization | 50.30M | 50.50M | 47.88M | 45.25M | 43.23M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 331.75M | 347.24M | 362.13M | 366.71M | 362.33M |
| Operating Income | -29.27M | -36.10M | -46.07M | -50.61M | -51.05M |
| Income Before Tax | -264.34M | -177.26M | -106.66M | -99.67M | -72.22M |
| Income Tax Expenses | 915.00K | 716.00K | 962.00K | 446.00K | 435.00K |
| Earnings from Continuing Operations | -265.26 | -177.97 | -107.62 | -100.12 | -72.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -265.26M | -177.97M | -107.62M | -100.12M | -72.66M |
| EBIT | -29.27M | -36.10M | -46.07M | -50.61M | -51.05M |
| EBITDA | 7.93M | 1.90M | -9.78M | -16.26M | -18.03M |
| EPS Basic | -3.72 | -2.53 | -1.58 | -1.51 | -1.15 |
| Normalized Basic EPS | -0.41 | -0.47 | -0.56 | -0.59 | -0.56 |
| EPS Diluted | -3.72 | -2.53 | -1.58 | -1.51 | -1.15 |
| Normalized Diluted EPS | -0.41 | -0.47 | -0.56 | -0.59 | -0.56 |
| Average Basic Shares Outstanding | 283.59M | 279.55M | 270.93M | 261.00M | 250.67M |
| Average Diluted Shares Outstanding | 283.59M | 279.55M | 270.93M | 261.00M | 250.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |